Details for 2021153365

Up to date per 04.04.2026

Actions

Title / Product Name

BISPEZIFISCH ANTIKÖRPER FÜR DLL3 UND CD3

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021153365

EP Publication Number

3865514

E-Number

1885592

Language

PCT Number

Publication Date

18.08.2021 A

11.02.2026 B1

Registration Date

11.02.2026

AT Publication Date

15.03.2026

Application Date

01.08.2016

Registration Number

Priorities

31.07.2015

201562199930 P

03.02.2016

201662290896 P

IPC

C07K 16/28 20060101AFI20210623BHEP

Maximum Duration of Protection

01.08.2036

Owner

Amgen Research (Munich) GmbHStaffelseestrasse 2 81477 MünchenDE

Representative

No representatives present

Inventor

Raum, Tobiasc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Kufer, Peterc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Pendzialek, Jochenc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Bluemel, Claudiac/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Dahlhoff, Christophc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Hoffmann, Patrickc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Lutterbuese, Ralfc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Nahrwold, Elisabethc/o Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 MunichDE

Information about Fees